Fundz

Polyembo secures funding led by a strategic investor to advance its innovative vascular embolic technology, the Scrunchy. The funding will support product development and regulatory clearances.

PRIVATEOct 24, 2025

Round Type

Funding Round

LongmontManufacturingBiotechnologyHealth CareMedicalmedical devices

Investors

Strategic Investor

Description

Polyembo, a medical device company, announced the closure of a new funding round. The funding, led by a multinational strategic investor, will be utilized for advancing their vascular embolization technologies. The Scrunchy device addresses existing challenges with current products. This funding marks a significant step forward for Polyembo's product development and regulatory efforts.

Company Information

Company

Polyembo

Location

350 Terry St

Longmont, Colorado, United States

About

Polyembo is a privately held medical device company focused on developing novel vascular embolization technologies such as the Scrunchy, Sphere, and PuffyCoil. These innovative devices aim to enhance the precision and efficiency of embolic procedures, addressing key challenges faced in the market. The Scrunchy is designed to provide rapid occlusion with a simplified inventory requirement. Currently, these products are under development and do not have marketing clearance or approval.

Fundz sees it the moment Polyembo raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsDJ A., Chief Technology Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Polyembo's next move

See what Strategic adds

Polyembo raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.